Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2003
06/19/2003US20030114354 Computer for producing a three-dimensional representation of a molecule or molecular complex
06/19/2003US20030113956 Display device formed of a multi-color light emitting material and method of making same
06/19/2003US20030113939 Modified surface for carrying out or detecting affinity reactions
06/19/2003US20030113938 Integrated protein affinity capture centrifugation device
06/19/2003US20030113934 Quantitative analysis; measuring radiation; transdermal monitoring
06/19/2003US20030113933 Analysis of components in liquids
06/19/2003US20030113931 Ammonia and ammonium sensors
06/19/2003US20030113930 Centrifuging white blood cells; separation; measuring concentration using television cameras
06/19/2003US20030113929 Testing a sample of fresh whole blood to determine whether a patient would benefit from the administration of a blood factor (such as antithrombin III)
06/19/2003US20030113928 Cancer diagnosis; analyzing for concentration of lysophosphatidic acid in lipid extract
06/19/2003US20030113927 Analyte measurement device and method of use
06/19/2003US20030113926 Centrifugal spectrometer
06/19/2003US20030113925 Nuclear morphology based identification and quantification of white blood cell types using optical bio-disc systems
06/19/2003US20030113911 In situ growth, freezing and testing of cultured cells
06/19/2003US20030113896 Medical diagnosis; detection of antibodies
06/19/2003US20030113888 Human ion channels
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113873 Screening modulators of G-protein coupled binding proteins; analgesics; muscle-relaxants; cognition activators; learning enhancement
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113869 Human FGF gene and gene expression products
06/19/2003US20030113868 Human metabotropic glutamate receptor subtype mGluR7b
06/19/2003US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction
06/19/2003US20030113843 For stimulating release of tumor necrosis factor, and/or cell proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; antiinflammatory agents; anticarcingenic agents; antitumor agents; cancer diagnosis
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113839 Histamine H2 receptor and uses
06/19/2003US20030113838 Epidermal growth factor; antitumor agents; antiproliferative agents; antiinflammatory agents; mitogen-activated protein kinases
06/19/2003US20030113833 Device for measuring extracellular potential, method of measuring extracellular potential by using the same and apparatus for quickly screening drug provided therewith
06/19/2003US20030113831 Detecting modulators of cytokine activity; bronchodilator agents; antiarthritic agents; glucocorticoids; leukotriene antagonists; corticosteroids
06/19/2003US20030113830 Evaluating haptoglobins antioxidant activity induced by hemoglobin; antidiabetic agents; for sustained release through stents
06/19/2003US20030113827 Detecting blood glucose concentration beneath target skin or mucosal surface; diabetes
06/19/2003US20030113826 Receptor/competetive binding assay comprising markers for human chorionic gonadotropin, carcinoembryonic antigen and alpha fetoprotein for accurate tumor/pregnancy detection; avoidance of hook effect
06/19/2003US20030113824 Dihydroxy unsaturated fatty acid levels as diagnostic markers
06/19/2003US20030113823 Comprises immobilized antigen from streptococcus mutants with ligand having affnity for human immunoglobulin A antibody; periodontal diseases; antitartar agents; microbiocides
06/19/2003US20030113822 Identification of anti-protozoal agents
06/19/2003US20030113821 Means of assaying immune function
06/19/2003US20030113820 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
06/19/2003US20030113818 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
06/19/2003US20030113817 Hemogen-EDAG: novel nuclear factors expressed in hematopoietic development
06/19/2003US20030113816 Methods of assaying connective tissue growth factor
06/19/2003US20030113814 Identification of modulators of gpr55 activity
06/19/2003US20030113813 Methods and devices for the integrated discovery of cell culture environments
06/19/2003US20030113812 Evaluating modulators of neuron propagation; bone morphogenetic proteins; epidermal growth factors; erythropoietins; pleiotrophins; hepatocyte growth factors; somatomedins; nerve growth factors; interleukins
06/19/2003US20030113811 Detecting membrane protein agonist/antagonist; alzheimer's diagnosis and treatment
06/19/2003US20030113810 Detecting modulator of G-protein coupled receptors; antilipotic agents; antidiabetic agents; bradycardial agents; anticoagulants; antisense agents
06/19/2003US20030113809 In vitro model for gastrointestinal inflammation
06/19/2003US20030113808 Apolipoprotein biopolymer markers predictive of alzheimers disease
06/19/2003US20030113807 Discrimination between different cellular pathways and their use in the determination of the effect of agents on cell culture
06/19/2003US20030113806 Determination of endometrial receptivity toward embryo implantation
06/19/2003US20030113805 Intrinsically labelled solid support
06/19/2003US20030113804 Automated salting out of proteins; storage stability; imaging; microarray formation; cancer diagnosis
06/19/2003US20030113803 Orphan receptor
06/19/2003US20030113801 FXIII detection for verifying serum sample and sample size and for detecting dilution
06/19/2003US20030113798 Antigenic peptides, such as for G protein-coupled receptors (GPCRS), antibodies thereto, and systems for identifying such antigenic peptides
06/19/2003US20030113797 Method for generating, screening and dereplicating natural product libraries for the discovery of therapeutic agents
06/19/2003US20030113795 Membrane protein; cytokines; antitumor agents; anticarcinogenic agents; antiinflammatory agents; cancer diagnosis
06/19/2003US20030113794 Immunoassay comprising additive such as triethanolamine; immobilization, incubation; drug screening
06/19/2003US20030113793 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113792 Epoxide polymer surfaces
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113782 MAP4Ks as modifiers of branching morphogenesis and methods of use
06/19/2003US20030113780 Antibodies to crosslinkers and methods for using the same
06/19/2003US20030113779 High-throughput assay for detection of conformational changes in RNA sequences; rev genes/proteins; fluorescent in situ hybridization
06/19/2003US20030113777 Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
06/19/2003US20030113776 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 54394
06/19/2003US20030113775 7118, a human arginine N-methyltransferase family member and uses therefor
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113767 Automated detection of homologies between nucleic acids; screening for clone accuracy; consistent reproduction of polymerase chain reaction products
06/19/2003US20030113766 Amine activated colorimetric resonant biosensor
06/19/2003US20030113764 Compositions and methods for the treatment of tumors
06/19/2003US20030113763 Oligonucleotide compositions and their use to induce apoptosis
06/19/2003US20030113762 Gleason grade 4/5 prostate cancer genes
06/19/2003US20030113761 Modelling of biochemical pathways
06/19/2003US20030113756 Computer/electronic database of biological information on cells, proteins, tissue and gene expression libraries
06/19/2003US20030113755 Fluorescent nucleotides and labeling methods using the same
06/19/2003US20030113753 Transmembrane proteins; age resistance; antiproliferative agents; cancer diagnosis; apoptosis
06/19/2003US20030113752 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening
06/19/2003US20030113751 Nuclear magnetic resonance assembly of chemical entities
06/19/2003US20030113750 Diagnosing cancer of urogenital systems using oligonucleotides/peptide nucleic acids or cytosine methylation; matrix assisted laser desorption ionization/electron spray mass spectrometry
06/19/2003US20030113749 Interaction trap systems for detecting protein interactions
06/19/2003US20030113748 Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins
06/19/2003US20030113746 Diagnosis of endometriosis from menstrual blood
06/19/2003US20030113744 Prevention/inhibition of organ damage due to hypoxia, stroke, heart attack, kidney disease and organ transplantation; antiischemic agents; drug screening
06/19/2003US20030113743 Method for detection of micrometastatic prostate cancer
06/19/2003US20030113742 Methods and compositions for the modulation of biofilm formation
06/19/2003US20030113741 Employing luciferase-luciferin bioluminescence generating system for identifying an analyte in a biological medium
06/19/2003US20030113733 Transcription factors; nuclear localization peptides; human chorionic gonadotropic hormone(hCG); NF-kappaB/Rel proteins
06/19/2003US20030113730 Pulse jet print head having multiple printhead dies and methods for use in the manufacture of biopolymeric arrays
06/19/2003US20030113728 Method for assessing the risk of cardiovascular disease
06/19/2003US20030113727 Genetic counseling; computer aided detection of genetic disorders
06/19/2003US20030113719 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113718 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113716 Nucleic acid multiplex formation
06/19/2003US20030113714 Binding peptides to polycrystalline semiconductors; detection of bacteriophages; high density magnetic storage; medical imaging; forensics; antitumor agents; anticarcinogenic agents
06/19/2003US20030113713 Methods and apparatus for conducting multiple measurements on a sample
06/19/2003US20030113711 Protein kinase peptide substrate determination using peptide libraries
06/19/2003US20030113709 Semiconductor nanocrystal-based cellular imaging
06/19/2003US20030113708 Methods of screening for toxicity of test compounds
06/19/2003US20030113343 Identification and characterization of novel pneumococcal choline binding protein, CbpG, and diagnostic and therapeutic uses thereof
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
1 ... 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 ... 3937